0001387131-18-001152.txt : 20180320 0001387131-18-001152.hdr.sgml : 20180320 20180320174225 ACCESSION NUMBER: 0001387131-18-001152 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180316 FILED AS OF DATE: 20180320 DATE AS OF CHANGE: 20180320 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Braunstein Douglas L CENTRAL INDEX KEY: 0001495110 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37406 FILM NUMBER: 18702782 MAIL ADDRESS: STREET 1: HUDSON EXECUTIVE CAPITAL LP STREET 2: 1185 AVENUE OF THE AMERICAS, 32ND FL CITY: NEW YORK STATE: NY ZIP: 10036 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Corindus Vascular Robotics, Inc. CENTRAL INDEX KEY: 0001528557 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 300687898 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 309 WAVERLEY OAKS ROAD STREET 2: SUITE 105 CITY: WALTHAM STATE: MA ZIP: 02452 BUSINESS PHONE: 508-653-3335 MAIL ADDRESS: STREET 1: 309 WAVERLEY OAKS ROAD STREET 2: SUITE 105 CITY: WALTHAM STATE: MA ZIP: 02452 FORMER COMPANY: FORMER CONFORMED NAME: Your Internet Defender, Inc DATE OF NAME CHANGE: 20110824 3 1 braunstein-form3_031618.xml OWNERSHIP DOCUMENT X0206 3 2018-03-16 0 0001528557 Corindus Vascular Robotics, Inc. CVRS 0001495110 Braunstein Douglas L HUDSON EXECUTIVE CAPITAL LP 570 LEXINGTON AVENUE, 35TH FLOOR NEW YORK NY 10022 1 0 0 0 Common Stock 11336154 I See footnote Series A Preferred Stock 1.25 2018-03-16 Common Stock 10800000 I See footnote Warrant 1.40 2018-09-16 2028-03-16 Common Stock 4725000 I See footnote Hudson Executive Capital LP, a Delaware limited partnership ("Hudson Executive"), as the investment advisor to certain affiliated investment funds, and HEC Management GP LLC, a Delaware limited liability company ("Management GP"), as the general partner of Hudson Executive, may be deemed to be the beneficial owners of the securities beneficially reported on this Form 3. By virtue of Mr. Braunstein's position as Managing Partner of Hudson Executive and Managing Member of Management GP, Mr. Braunstein may be deemed to be the beneficial owner of the securities reported for purposes of Rule 16a-1(a). Mr. Braunstein disclaims any beneficial ownership of the securities reported, except to the extent of any pecuniary interest therein. The preferred stock is perpetual and therefore has no expiration date. /s/ Douglas L. Braunstein 2018-03-20